{
    "2021-02-22": [
        [
            {
                "time": "2021-02-28",
                "original_text": "西部证券维持智飞生物买入评级：2020年业绩符合预期，看好公司“代理+自研”双轮驱动",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "代理+自研",
                        "双轮驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-03",
                "original_text": "3日重挫近20%，智飞生物跌出机会了吗？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重挫",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "26股获机构买入型评级 智飞生物关注度最高",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "买入型评级",
                        "关注度高"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-06",
                "original_text": "智飞生物：业绩符合预期 管线稳步推进商业化价值可期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "管线",
                        "商业化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-07",
                "original_text": "快讯 | 智飞生物业绩快报发布：疫苗产品销售稳定增长 实现营业收入151.9亿元净利润33亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩快报",
                        "疫苗",
                        "营收",
                        "净利润"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-08",
                "original_text": "西南证券 - 智飞生物:业绩符合预期，代理产品持续放量",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "代理产品",
                        "放量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-09",
                "original_text": "持续专注疫苗及生物品研发，智飞生物去年营利齐增",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "疫苗",
                        "研发",
                        "营利齐增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-10",
                "original_text": "华西证券维持智飞生物买入评级：利润延续高增长，新冠疫苗有望大幅增厚业绩",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "买入评级",
                        "利润",
                        "新冠疫苗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-11",
                "original_text": "国金证券 - 智飞生物：业绩符合预期，重磅产品管线有序推进",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "重磅产品",
                        "管线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-12",
                "original_text": "中泰证券维持智飞生物买入评级：业绩高速增长，新冠疫苗临床Ⅲ期进展顺利",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "买入评级",
                        "业绩",
                        "新冠疫苗",
                        "临床Ⅲ期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}